Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of lip, oral cavity and pharynx (C00-C14)»Malignant neoplasm of nasopharynx, unspecified (C11.9)
C11.9
Malignant neoplasm of nasopharynx, unspecified
Related indications (MeSH) (1)
Nasopharyngeal Carcinoma209 drugs (87 approved, 122 experimental)
A carcinoma that originates in the EPITHELIUM of the NASOPHARYNX and includes four subtypes: keratinizing squamous cell, non-keratinizing, basaloid squamous cell, and PAPILLARY ADENOCARCINOMA. It is most prevalent in Southeast Asian populations and is associated with EPSTEIN-BARR VIRUS INFECTIONS. Somatic mutations associated with this cancer have been identified in NPCR, BAP1, UBAP1, ERBB2, ERBB3, MLL2, PIK3CA, KRAS, NRAS, and ARID1A genes.